Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBKIR.L Regulatory News (BKIR)

  • There is currently no data for BKIR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Commercial Loan Portfolio

5 Feb 2015 10:30

RNS Number : 1428E
Bank of Ireland(Governor&Co)
05 February 2015
 



The Governor and Company of the Bank of Ireland ('Bank of Ireland')

 

Acquisition of Performing Commercial Loan Portfolio

___________________________________________________________________________

 

Bank of Ireland and Goldman Sachs have agreed terms to acquire a commercial loan portfolio of face value €540m from Danske Bank A/S. As part of the transaction, Bank of Ireland will acquire a €274m portfolio of performing commercial loans, comprising over 1,000 customers in the SME, Agriculture and CRE sectors. Goldman Sachs in conjunction with Pepper Asset Servicing, as servicer, will acquire the balance of the portfolio. The transaction is expected to close shortly.

 

Mr Mark Cunningham, Director of Bank of Ireland Business Banking commented "Bank of Ireland is pleased to have been able to avail of this opportunity to demonstrate our ongoing focus on further growing and developing our strong position in serving the business and agri sectors in Ireland. We look forward to welcoming these new customers to Bank of Ireland and working with them as they seek to develop and grow their own businesses and enterprises".

 

 

Ends.

 

For further information please contact:

 

Bank of Ireland

Andrew Keating Group Chief Financial Officer +353 (0)766 23 5141

Mark Spain Director of Group Investor Relations +353 (0)766 23 4850

Pat Farrell Head of Group Communications +353 (0)766 23 4770

 

Forward Looking Statement

 

This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934 and Section 27A of the US Securities Act of 1933 with respect to certain of the Bank of Ireland Group's (the 'Group') plans and its current goals and expectations relating to its future financial condition and performance, the markets in which it operates, and its future capital requirements. These forward-looking statements often can be identified by the fact that they do not relate only to historical or current facts. Generally, but not always, words such as 'may,' 'could,' 'should,' 'will,' 'expect,' 'intend,' 'estimate,' 'anticipate,' 'assume,' 'believe,' 'plan,' 'seek,' 'continue,' 'target,' 'goal,' 'would,' or their negative variations or similar expressions identify forward-looking statements, but their absence does not mean that a statement is not forward looking. Examples of forward-looking statements include among others, statements regarding the Group's near term and longer term future capital requirements and ratios, level of ownership by the Irish Government, loan to deposit ratios, expected impairment charges, the level of the Group's assets, the Group's financial position, future income, business strategy, projected costs, margins, future payment of dividends, the implementation of changes in respect of certain of the Group's pension schemes, estimates of capital expenditures, discussions with Irish, United Kingdom, European and other regulators and plans and objectives for future operations.

 

Such forward-looking statements are inherently subject to risks and uncertainties, and hence actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to, the following: geopolitical risks, such as those associated with crises in the Middle East and increasing political tensions in respect of the Ukraine, which could potentially adversely impact the markets in which the Group operates; concerns on sovereign debt and financial uncertainties in the EU and in member countries and the potential effects of those uncertainties on the Group; general and sector specific economic conditions in Ireland, the United Kingdom and the other markets in which the Group operates; the ability of the Group to generate additional liquidity and capital as required; any capital or other assessments undertaken by regulators; property market conditions in Ireland and the United Kingdom; the potential exposure of the Group to various types of market risks, such as interest rate risk, foreign exchange rate risk, credit risk and commodity price risk; deterioration in the credit quality of the Group's borrowers and counterparties, as well as increased difficulties in relation to the recoverability of loans and other amounts due from such borrowers and counterparties, have resulted in significant increases, and could result in further significant increases, in the Group's impaired loans and impairment provisions; implications of the Personal Insolvency Act 2012 and measures introduced by the Central Bank of Ireland to address mortgage arrears on the Group's distressed debt recovery and impairment provisions; the impact on lending and other activity arising from the emerging macro prudential policies; the performance and volatility of international capital markets; the effects of the Irish Government's stockholding in the Group (through the Ireland Strategic Investment Fund) and possible changes in the level of such stockholding; the impact of downgrades in the Group's or the Irish Government's credit ratings or outlook; the stability of the Eurozone; changes in the Irish and United Kingdom banking systems; changes in applicable laws, regulations and taxes in jurisdictions in which the Group operates particularly banking regulation by the Irish and United Kingdom Governments together with implementation of the Single Supervisory Mechanism and establishment of the Single Resolution Mechanism; the exercise by regulators of powers of regulation and oversight in Ireland and the United Kingdom; the introduction of new government policies or the amendment of existing policies in Ireland or the United Kingdom; the outcome of any legal claims brought against the Group by third parties or legal or regulatory proceedings or any Irish banking inquiry more generally, that may have implications for the Group; the development and implementation of the Group's strategy, including the Group's ability to achieve net interest margin increases and cost reductions; the responsibility of the Group for contributing to compensation schemes in respect of banks and other authorised financial services firms in Ireland and the United Kingdom that may be unable to meet their obligations to customers; the inherent risk within the Group's life assurance business involving claims, as well as market conditions generally; potential further contributions to the Group sponsored pension schemes if the value of pension fund assets is not sufficient to cover potential obligations; the exposure of the Group to NAMA losses in the event that NAMA has an underlying loss at the conclusion of its operations, which could adversely impact the Group's capital and results of operations; the impact of the continuing implementation of significant regulatory developments such as Basel III, Capital Requirements Directive (CRD) IV, Solvency II and the Recovery and Resolution Directive; and the Group's ability to address weaknesses or failures in its internal processes and procedures including information technology issues and equipment failures and other operational risks.

 

Nothing in this document should be considered to be a forecast of future profitability or financial position and none of the information in this document is or is intended to be a profit forecast or profit estimate. Any forward-looking statement speaks only as at the date it is made. The Group does not undertake to release publicly any revision to these forward-looking statements to reflect events, circumstances or unanticipated events occurring after the date hereof. The reader should however, consult any additional disclosures that the Group has made or may make in documents filed or submitted or may file or submit to the US Securities and Exchange Commission.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQTAMMTMBBMBRA
Date   Source Headline
29th Jul 20119:00 amRNSNotices available from Morningstar
29th Jul 20117:00 amRNSMSM - Cancellation Notice
27th Jul 20115:59 pmRNSSignificant Investment in Bank of Ireland
27th Jul 20114:56 pmRNSResults of the Rights Issue Rump Placement
26th Jul 20113:15 pmRNSRepurchase
26th Jul 201111:00 amRNSMSM - Cancellation Notice
25th Jul 20114:27 pmRNSNotice to Noteholders
25th Jul 20117:00 amRNSSignificant Investment in Bank of Ireland
25th Jul 20117:00 amRNSMSM - Cancellation Notice
22nd Jul 201112:00 pmRNSDirector/PDMR Shareholding
18th Jul 201110:47 amRNSMeeting Results
18th Jul 201110:39 amRNSMeeting Results
18th Jul 20119:30 amRNSNotices available from Morningstar
15th Jul 20115:37 pmRNSBank of Ireland Passes the 2011 EBA Stress Test
14th Jul 20111:02 pmRNSPut Option
12th Jul 20119:22 amRNSRights Issue Update
11th Jul 20114:53 pmRNSExchange Offer Conditions
11th Jul 20114:30 pmRNSAvailability of Rights Issue Documentation
11th Jul 20114:21 pmRNSResult of EGM
11th Jul 20117:01 amRNSPublication of Supplementary Prospectus
11th Jul 20117:00 amRNSRights Issue Terms
8th Jul 20114:00 pmRNSBank of Ireland First Results Announcement
1st Jul 201112:00 pmRNSBlocklisting Interim Review
28th Jun 20115:47 pmRNSDirector/PDMR Shareholding
28th Jun 20117:00 amRNSTermination of Exchange Offer £75,000,000 13.375%
27th Jun 20112:16 pmRNSRepurchase
27th Jun 20117:00 amRNSForm 20F and Pillar 3 Disclosures Availability
23rd Jun 20114:44 pmRNSUpdate on Capital Raising
23rd Jun 20112:38 pmRNSExchange Offers & Consent Solicitations - Update
20th Jun 20114:22 pmRNSUpdate-Exchange Offers and Consent Solicitations
20th Jun 20117:01 amRNSPublication of Prospectus and Circular
20th Jun 20117:00 amRNSAvailability of Documents & Capital Raising Update
15th Jun 20115:50 pmRNSDirectorate Change
15th Jun 20115:45 pmRNSResult of AGM
14th Jun 20112:41 pmRNSAmendment to Exchange Offer ISIN GB0000510312
9th Jun 201112:00 pmRNSAppointment of Senior Independent Director
8th Jun 20115:57 pmRNSNotice of A Meeting
8th Jun 20115:27 pmRNSExchange Offers and Consent Solicitations
8th Jun 20115:26 pmRNSAnnouncement of Further Details of Capital Raising
3rd Jun 20114:00 pmRNSForm TR1
3rd Jun 201110:30 amRNSCapital Raising - Further Update
1st Jun 201112:00 pmRNSSale of Bank of Ireland Securities Services
31st May 201112:00 pmRNSCapital Raising Update
19th May 20117:00 amRNSInterim Management Statement
13th May 20114:30 pmRNSAnnual Information Update
12th May 20116:10 pmRNSAvailability of AGC Documents
11th May 20115:10 pmRNSPut Option
10th May 20116:05 pmRNSForthcoming AGC and Director Changes
9th May 20115:30 pmRNSUpdate on EU Restructuring and Viability Plan
5th May 20119:23 amRNSRepurchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.